Current protocols and outcomes of ABO-incompatible kidney transplantation

doi:10.5500/wjt.v10.i7.191

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10137)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

797

WORD

222

HTML

5994

Figures (1-5)

274

Tables (1-3)

227

Sum=7514

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

329

Download

565

Sum=894

Publishing Process of This Article

Item

Count

Browse

711

Download

1018

Sum=1729

Jul 29, 2020 (publication date) through May 5, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Transplant. Jul 29, 2020; 10(7): 191-205
Published online Jul 29, 2020. doi: 10.5500/wjt.v10.i7.191

Open in New Tab Full Size Figure Download Figure

Figure 1 Main steps in the development of desensitization. IVIG: Intravenous immunoglobulin.

Open in New Tab Full Size Figure Download Figure

Figure 2 Scheme of desensitization treatment. IVIG: Intravenous immunoglobulin; RTX: Rituximab.

Open in New Tab Full Size Figure Download Figure

Figure 3 Tailored desensitization strategy. DFPP: Double filtration plasmapheresis.

Open in New Tab Full Size Figure Download Figure

Figure 4 Kaplan–Meier survival curve of patient survival at 3 yr. Tailored desensitization, ABOc versus ABOi.

Open in New Tab Full Size Figure Download Figure

Figure 5 Kaplan-Meier survival curve of rejection free survival post-transplant. Tailored desensitization, ABOc versus ABOi.

Citation: Salvadori M, Tsalouchos A. Current protocols and outcomes of ABO-incompatible kidney transplantation. World J Transplant 2020; 10(7): 191-205
URL: https://www.wjgnet.com/2220-3230/full/v10/i7/191.htm
DOI: https://dx.doi.org/10.5500/wjt.v10.i7.191